KLRS

Kalaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for serious medical conditions. The company's pipeline typically addresses unmet medical needs in areas such as oncology, immunology, or rare diseases through innovative drug candidates. Kalaris applies modern drug discovery and development approaches to advance its therapeutic programs through clinical trials. As a development-stage company, it focuses on bringing novel treatments from research into patient care.